Chemoinformaics analysis of Methyl 4-chloro-2,2-dimethyl-4-pentenoate
| Molecular Weight | 176.643 | nRot | 3 |
| Heavy Atom Molecular Weight | 163.539 | nRig | 2 |
| Exact Molecular Weight | 176.06 | nRing | 0 |
| Solubility: LogS | -2.302 | nHRing | 0 |
| Solubility: LogP | 2.64 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 24 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 0 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 13 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 8 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 25.8123 |
| nHD | 0 | BPOL | 16.1557 |
| QED | 0.617 |
| Synth | 2.917 |
| Natural Product Likeliness | 0.389 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0 |
| HIA | 0.004 |
| CACO-2 | -4.467 |
| MDCK | 0.0000448 |
| BBB | 0.995 |
| PPB | 0.460115 |
| VDSS | 1.023 |
| FU | 0.640149 |
| CYP1A2-inh | 0.542 |
| CYP1A2-sub | 0.689 |
| CYP2c19-inh | 0.44 |
| CYP2c19-sub | 0.849 |
| CYP2c9-inh | 0.06 |
| CYP2c9-sub | 0.613 |
| CYP2d6-inh | 0.012 |
| CYP2d6-sub | 0.712 |
| CYP3a4-inh | 0.037 |
| CYP3a4-sub | 0.319 |
| CL | 7.758 |
| T12 | 0.387 |
| hERG | 0.012 |
| Ames | 0.955 |
| ROA | 0.141 |
| SkinSen | 0.113 |
| Carcinogencity | 0.945 |
| EI | 0.229 |
| Respiratory | 0.901 |
| NR-Aromatase | 0.014 |
| Antiviral | No |
| Prediction | 0.93641 |